©EMEA 2007 Reproduction and/ or distribution of this document is authorised for non commercial purposes only provided the EMEA is acknowledged плацебо (сляпо лечение) при всичките 905 пациенти.
©EMEA 2007 Reproduction and/or distribution of this document is authorised for non commercial purposes only provided the EMEA is acknowledged Studie wurden die Wirkungen einer Anfangsbehandlung mit Natalizumab Elan Pharma und von Placebo (einem Scheinmedikament) bei allen 905 Patienten verglichen.